{"id":"https://openalex.org/W2018525392","doi":"https://doi.org/10.1177/1758834011423402","title":"c-MET: an exciting new target for anticancer therapy","display_name":"c-MET: an exciting new target for anticancer therapy","publication_year":2011,"publication_date":"2011-11-01","ids":{"openalex":"https://openalex.org/W2018525392","doi":"https://doi.org/10.1177/1758834011423402","mag":"2018525392","pmid":"https://pubmed.ncbi.nlm.nih.gov/22128286","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3225019"},"language":"en","primary_location":{"id":"doi:10.1177/1758834011423402","doi":"https://doi.org/10.1177/1758834011423402","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1758834011423402","pdf_url":null,"source":{"id":"https://openalex.org/S41085503","display_name":"Therapeutic Advances in Medical Oncology","issn_l":"1758-8340","issn":["1758-8340","1758-8359"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Medical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3225019","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072378199","display_name":"Johann Sebastian De Bono","orcid":"https://orcid.org/0000-0002-2034-595X","observed_orcids":["https://orcid.org/0000-0002-2034-595X"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Johann S. de Bono","raw_affiliation_strings":["Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, SM2 5PT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Downs Road, Sutton, Surrey, SM2 5PT, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068368047","display_name":"Timothy Anthony Yap","orcid":"https://orcid.org/0000-0002-2154-3309","observed_orcids":["https://orcid.org/0000-0002-2154-3309"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]},{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Timothy A. Yap","raw_affiliation_strings":["Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, Surrey, UK","institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5072378199"],"corresponding_institution_ids":["https://openalex.org/I1325846038","https://openalex.org/I142947616"],"apc_list":{"value":2800,"currency":"USD","value_usd":2800},"apc_paid":null,"fwci":0.4484,"has_fulltext":false,"cited_by_count":22,"citation_normalized_percentile":{"value":0.67335403,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"3","issue":"1_suppl","first_page":"S3","last_page":"S5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.8833000063896179,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.8833000063896179,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.03920000046491623,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.012500000186264515,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/c-met","display_name":"c-Met","score":0.8849999904632568},{"id":"https://openalex.org/keywords/hepatocyte-growth-factor","display_name":"hepatocyte growth factor","score":0.9629999995231628},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinases","display_name":"receptor tyrosine kinase","score":0.8619999885559082},{"id":"https://openalex.org/keywords/cancer-therapy","display_name":"cancer therapy","score":0.6100000143051147},{"id":"https://openalex.org/keywords/angiogenesis","display_name":"angiogenesis","score":0.6430000066757202},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.8989999890327454},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6190000176429749},{"id":"https://openalex.org/keywords/vegfr","display_name":"VEGFR","score":0.7739999890327454},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.8880000114440918},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7450000047683716},{"id":"https://openalex.org/keywords/c-met-kinase-inhibitors","display_name":"c-Met inhibitor","score":0.6100000143051147},{"id":"https://openalex.org/keywords/tissue-homeostasis","display_name":"tissue homeostasis","score":0.6909999847412109},{"id":"https://openalex.org/keywords/tumor-invasion","display_name":"tumor invasion","score":0.5370000004768372},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.3779999911785126}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8270509243011475},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37940892577171326}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1177/1758834011423402","doi":"https://doi.org/10.1177/1758834011423402","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1758834011423402","pdf_url":null,"source":{"id":"https://openalex.org/S41085503","display_name":"Therapeutic Advances in Medical Oncology","issn_l":"1758-8340","issn":["1758-8340","1758-8359"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Medical Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3225019","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3225019","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Adv Med Oncol","raw_type":"Text"},{"id":"pmid:22128286","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22128286","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic advances in medical oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:b7fe09a42819448c9b2062da7d341773","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/b7fe09a42819448c9b2062da7d341773","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Therapeutic Advances in Medical Oncology, Vol 3 (2011)","raw_type":"article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3225019","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3225019","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Adv Med Oncol","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320338262","display_name":"Daiichi Sankyo Europe","ror":"https://ror.org/01qhj1g70"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1972607682","https://openalex.org/W1977889545","https://openalex.org/W1985995844","https://openalex.org/W1986159749","https://openalex.org/W1994912526","https://openalex.org/W1998450601","https://openalex.org/W2022527563","https://openalex.org/W2029480581","https://openalex.org/W2031981310","https://openalex.org/W2052378862","https://openalex.org/W2074242691","https://openalex.org/W2103146352","https://openalex.org/W2114556798","https://openalex.org/W2125519805","https://openalex.org/W2125954956","https://openalex.org/W2136390065","https://openalex.org/W2148479145","https://openalex.org/W2148885898","https://openalex.org/W2159959305","https://openalex.org/W2219581640","https://openalex.org/W2279974145"],"related_works":["https://openalex.org/W1513405953","https://openalex.org/W1992031126","https://openalex.org/W1985562847","https://openalex.org/W2141203222","https://openalex.org/W2111842868","https://openalex.org/W1980785869","https://openalex.org/W2074904551","https://openalex.org/W2031431198","https://openalex.org/W2062110561","https://openalex.org/W2391185526"],"abstract_inverted_index":{"The":[0,417,729],"c-MET":[1,90,105,127,151,184,198,240,274,284,308,337,344,380,404,413,425,547,681,773,843,904,907],"receptor":[2,165,171,185,345],"tyrosine":[3,346,405,578,682],"kinase,":[4],"along":[5],"with":[6,133,213,332,375,443,465,476,485,499,535,595,687,718],"its":[7,312,393],"ligand":[8,313],"hepatocyte":[9],"growth":[10,163,169,369],"factor":[11,164,170,206],"(HGF),":[12],"plays":[13],"an":[14,203,702,861,881],"important":[15,785],"role":[16],"in":[17,64,131,154,302,362,370,382,433,441,454,463,467,489,496,521,533,549,601,619,637,777,814,852,897,924],"the":[18,51,57,65,89,180,183,248,271,305,336,343,356,423,468,482,500,613,628,643,678,707,733,756,769,795,832,842,853,877,892,903,925,928],"regulation":[19,66,116],"and":[20,30,39,73,140,167,186,207,216,224,245,278,316,401,459,470,492,589,722,736,749,758,765,802,820,834,859,913,921,927],"control":[21],"of":[22,67,88,98,104,251,261,273,283,289,293,307,311,319,335,342,358,390,422,546,552,604,612,615,631,642,664,680,709,738,760,772,797,836,855,931],"tissue":[23],"homeostasis":[24],"under":[25],"normal":[26],"physiological":[27],"conditions":[28],"[Yap":[29],"de":[31],"Bono,":[32],"2010;":[33,724,822],"Ma":[34,79],"et":[35,43,47,76,80,84,118,136,144,193,229,323,327,446,561,608,726,824],"al.":[36,44,48,77,81,85,119,137,145,194,230,324,328,447,562,609,727,825],"2003;":[37],"Trusolino":[38],"Comoglio,":[40,141],"2002;":[41],"Bladt":[42],"1995;":[45],"Schmidt":[46],"1995].":[49],"However,":[50],"HGF/c-MET":[52,359,633,644,739],"pathway":[53,92,338,360,635],"(also":[54],"known":[55],"as":[56,160,202,258,285,657,662,753,755,908],"\u2018HGF/MET":[58],"axis\u2019)":[59],"has":[60,128,188,365,504,567],"also":[61,124,208,830],"been":[62,190],"implicated":[63],"cancer":[68,134,252,320,437,654,719,743],"cell":[69,435],"growth,":[70],"angiogenesis,":[71],"invasion":[72],"metastasis":[74],"[Liu":[75],"2008;":[78,82,138,325],"Birchmeier":[83],"2003].":[86],"Activation":[87],"signaling":[91,634,844,905],"can":[93],"occur":[94],"via":[95],"a":[96,259,266,286,351,367,486,493,511,550,576,649,658,665,696,778,789,798,803,815,909],"number":[97],"mechanisms,":[99],"including":[100],"activating":[101],"mutations,":[102],"overexpression":[103],"itself":[106],"or":[107,109,113,309,661,693],"HGF,":[108],"through":[110,179,222],"autocrine,":[111],"paracrine":[112],"endocrine":[114],"loop":[115],"[Cecchi":[117],"2010].":[120,448,728,826],"Research":[121],"studies":[122,298,594],"have":[123,299,597,860],"demonstrated":[125,430,598],"that":[126,150,210,219,301,566,581,788],"prognostic":[129],"implications":[130],"patients":[132,455,540,606,717],"[Beau-Faller":[135],"Boccaccio":[139],"2006;":[142],"Cheng":[143],"2005].\r\n\r\nIt":[146],"is":[147,152,265,519,573,622,695,701,784],"now":[148,381,505],"clear":[149],"involved":[153],"resistance":[155],"to":[156,200,238,246,269,279,349,395,480,537,557,624,675,705,775,786,811,849],"established":[157],"agents,":[158],"such":[159],"vascular":[161],"endothelial":[162],"(VEGFR)":[166],"epidermal":[168],"(EGFR)":[172],"inhibitors.":[173],"For":[174,768],"example,":[175],"increased":[176],"tumor":[177,599],"survival":[178,217,450,554],"cooperation":[181],"between":[182],"VEGFR":[187],"previously":[189],"reported":[191],"[Eder":[192,228],"2009].":[195,231],"In":[196,330],"addition,":[197],"appears":[199,348],"act":[201],"independent":[204],"angiogenic":[205,214,226],"one":[209],"may":[211,234,793],"interact":[212],"proliferation":[215],"signals":[218],"are":[220,672,871],"promoted":[221,257],"VEGF":[223],"other":[225,837],"proteins":[227],"Thus,":[232],"there":[233],"be":[235,256,350,625,794],"therapeutic":[236,616,667,699,714,781,911],"utility":[237],"suppressing":[239],"activity":[241,432],"when":[242,439],"targeting":[243,379],"angiogenesis":[244],"prevent":[247],"potential":[249,910],"dissemination":[250],"cells,":[253],"which":[254,846,888],"would":[255],"result":[260,776],"intratumoral":[262],"oxygen":[263],"deprivation.\r\n\r\nIt":[264],"logical":[267],"step":[268],"consider":[270],"prevention":[272],"dependent":[275],"neoplastic":[276],"processes":[277],"target":[280,799,884,912],"distinct":[281],"functions":[282],"novel":[287,340,856],"strategy":[288,652],"treating":[290],"invasive":[291],"tumors":[292,542],"high":[294,544],"metastatic":[295,317],"potential.":[296],"Preclinical":[297],"shown":[300],"animal":[303],"models,":[304],"inhibition":[306,334],"neutralization":[310],"impairs":[314],"tumorigenic":[315],"properties":[318],"cells":[321],"[Corso":[322],"Petrelli":[326],"2006].":[329],"line":[331],"this,":[333],"using":[339,531],"inhibitors":[341,389,414,641,684,774],"kinase":[347,406,579,683],"promising":[352,650],"treatment":[353,744],"option.":[354],"Indeed,":[355],"prevalence":[357],"activation":[361,636],"human":[363],"malignancies":[364],"driven":[366],"rapid":[368],"oncology":[371],"drug":[372],"development":[373,621,735,771],"programmes,":[374],"several":[376],"new":[377,651,883],"agents":[378,386,617,690],"clinical":[383,410,420,529,571,593,620,670,816,916,929],"trials.":[384],"These":[385],"include":[387,745,902],"direct":[388],"HGF":[391],"and/or":[392],"binding":[394],"c-MET,":[396,400,518,583],"antibodies":[397],"targeted":[398,689,740],"at":[399,876],"small":[402],"molecule":[403],"inhibitors.\r\n\r\nResults":[407],"from":[408,555],"recent":[409,526],"trials":[411,572,671,917],"evaluating":[412,918],"appear":[415],"promising.":[416],"phase":[418,507,522,527,569],"II":[419,523,528],"trial":[421,530],"specific":[424],"inhibitor":[426,580],"tivantinib":[427,460],"(ARQ":[428],"197)":[429],"antitumor":[431,763,857],"non-small":[434],"lung":[436],"(NSCLC),":[438],"administered":[440],"combination":[442,501,534,679,766],"erlotinib":[444,458,469,536],"[Schiller":[445],"Progression-free":[449],"(PFS)":[451],"was":[452],"prolonged":[453],"who":[456],"received":[457],"(16.1":[461],"weeks),":[462],"contrast":[464],"those":[466],"placebo":[471],"arm":[472],"(9.7":[473],"weeks).":[474],"Patients":[475],"nonsquamous":[477],"histology":[478],"appeared":[479],"gain":[481],"greatest":[483],"benefit,":[484],"9.2-week":[487],"improvement":[488,495],"median":[490,497],"PFS":[491],"13.7-week":[494],"OS":[498],"therapy.":[502],"Tivantinib":[503],"entered":[506],"III":[508],"development.":[509,524],"MetMAb,":[510],"monovalent":[512],"monoclonal":[513],"antibody":[514],"(mAb)":[515],"directed":[516],"against":[517,691],"currently":[520,618],"A":[525],"MetMAb":[532],"treat":[538],"NSCLC":[539],"whose":[541],"expressed":[543],"levels":[545],"resulted":[548],"tripling":[551],"patient":[553,747,800,864],"4.6":[556],"12.6":[558],"months":[559],"[Spigel":[560],"2011].":[563],"Another":[564],"agent":[565,660],"reached":[568],"II/III":[570],"cabozantinib":[574,596],"(XL184),":[575],"potent":[577],"blocks":[582],"VEGFR2,":[584],"AXL,":[585],"KIT,":[586],"TIE2,":[587],"FLT3":[588],"RET":[590],"signaling.":[591],"Impressively,":[592],"shrinkage":[600],"almost":[602],"60%":[603],"glioblastoma":[605],"[Wen":[607],"2010].\r\n\r\nThe":[610],"efficacy":[611,854],"myriad":[614],"likely":[623],"influenced":[626],"by":[627],"underlying":[629],"mechanism":[630],"aberrant":[632],"different":[638],"cancers.":[639],"Such":[640],"axis":[645],"will":[646,829],"hopefully":[647],"offer":[648],"for":[653,716,742,791,885],"treatment,":[655],"either":[656,688],"single":[659],"part":[663],"combinatorial":[666],"approach.":[668],"Several":[669],"already":[673],"underway":[674],"determine":[676],"whether":[677],"given":[685],"together":[686],"EGFR/VEGF":[692],"chemotherapy":[694],"clinically":[697,779],"effective":[698,734,780],"approach.\r\n\r\nThere":[700],"urgent":[703],"need":[704],"accelerate":[706],"transition":[708],"preclinical":[710],"research":[711],"into":[712],"better":[713],"approaches":[715],"[de":[720,818],"Bono":[721,819],"Ashworth,":[723,821],"Yap":[725,823],"main":[730],"challenges":[731,828],"facing":[732],"use":[737],"therapies":[741,858],"optimal":[746],"selection":[748,796],"diagnostic/pharmacodynamic":[750],"biomarker":[751,809],"development,":[752],"well":[754],"identification":[757],"testing":[759],"rationally":[761],"designed":[762],"drugs":[764],"strategies.":[767],"ongoing":[770,915],"approach,":[782],"it":[783],"highlight":[787],"requirement":[790],"this":[792,869],"population":[801],"practical":[804],"but":[805],"analytically":[806],"validated":[807],"predictive":[808],"assay":[810],"identify":[812],"them":[813],"context":[817],"Future":[827],"involve":[831],"investigation":[833],"dissection":[835],"vital":[838],"crosstalk":[839],"mechanisms":[840],"involving":[841],"pathway,":[845,906],"could":[847],"lead":[848],"greater":[850],"improvements":[851],"impact":[862],"on":[863,873],"survival.\r\n\r\nThe":[865],"articles":[866],"contained":[867],"within":[868],"supplement":[870],"based":[872],"content":[874],"presented":[875],"satellite":[878],"symposium":[879],"\u2018c-MET:":[880],"exciting":[882],"anticancer":[886],"therapy\u2019":[887],"took":[889],"place":[890],"during":[891],"Targeted":[893],"Anticancer":[894],"Therapies":[895],"meeting":[896],"Paris,":[898],"2011.":[899],"Topics":[900],"covered":[901],"biomarker,":[914],"c-MET-inhibiting":[919],"drugs,":[920],"future":[922],"directions":[923],"laboratory":[926],"evaluation":[930],"c-MET-driven":[932],"malignancies.":[933]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}